Dimensional Fund Advisors LP Lowers Position in National Research Co. (NASDAQ:NRC)

Dimensional Fund Advisors LP trimmed its position in shares of National Research Co. (NASDAQ:NRC) by 3.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 614,495 shares of the company’s stock after selling 23,894 shares during the quarter. Dimensional Fund Advisors LP owned 2.57% of National Research worth $14,103,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. raised its position in National Research by 860.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock worth $45,000 after acquiring an additional 1,015 shares during the period. CWM LLC raised its holdings in shares of National Research by 889.7% in the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock worth $27,000 after purchasing an additional 1,041 shares during the period. Principal Financial Group Inc. purchased a new position in National Research in the first quarter valued at approximately $221,000. Precision Wealth Strategies LLC increased its position in National Research by 7.9% in the first quarter. Precision Wealth Strategies LLC now owns 5,623 shares of the company’s stock worth $223,000 after buying an additional 413 shares during the last quarter. Finally, BOKF NA bought a new stake in shares of National Research in the first quarter valued at $243,000. Institutional investors own 47.26% of the company’s stock.

National Research Stock Down 1.4 %

NRC opened at $19.97 on Friday. National Research Co. has a 12 month low of $19.92 and a 12 month high of $46.87. The company has a market cap of $476.82 million, a PE ratio of 16.10 and a beta of 0.49. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.64. The company has a 50 day moving average of $22.05 and a 200 day moving average of $27.30.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The business had revenue of $35.02 million for the quarter.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.40%. The ex-dividend date of this dividend is Friday, September 27th. National Research’s dividend payout ratio is 38.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.